Stay updated on HepTcell Immunotherapy in Inactive CHB Clinical Trial

Sign up to get notified when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HepTcell Immunotherapy in Inactive CHB Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a software/configuration update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-05-18T03:56:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page’s displayed UI revision/version was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:23:26.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:40:20.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0. No study information or functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-03-21T16:48:28.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-06T18:57:17.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No substantive study content or navigation changes were observed.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:43.000Z thumbnail image

Stay in the know with updates to HepTcell Immunotherapy in Inactive CHB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.